德国不同运动项目优秀女运动员月经功能障碍及激素避孕药的使用情况

IF 5.9 2区 医学 Q1 SPORT SCIENCES
Elisabeth M Kirschbaum, Katharina Fischer, Dorothee Speiser, Franziska Lautenbach, Friedemann Schwenkreis, Anne Dathan-Stumpf, Kirsten Legerlotz
{"title":"德国不同运动项目优秀女运动员月经功能障碍及激素避孕药的使用情况","authors":"Elisabeth M Kirschbaum, Katharina Fischer, Dorothee Speiser, Franziska Lautenbach, Friedemann Schwenkreis, Anne Dathan-Stumpf, Kirsten Legerlotz","doi":"10.1186/s40798-025-00845-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>While a regular menstrual cycle is an indicator of good health, menstrual dysfunction (MD) and wrong beliefs regarding hormonal contraceptives (HC) are quite common among elite female athletes and threaten their health. This study aimed to (1) identify the prevalence of current and lifetime MD in various sports disciplines, (2) investigate variables that are associated with the prevalence of MD, (3) study the current practice of HC use among elite German female athletes.</p><p><strong>Methods: </strong>584 German elite female athletes (mean 20.7 ± 4.9 years) from 64 different sports completed an online questionnaire to assess gynecological health characteristics, history of MD, and the use of HC.</p><p><strong>Results: </strong>Sixty-nine percent of athletes not using HC reported a regular menstrual cycle, while oligomenorrhea was currently reported in 13%, secondary amenorrhea in 8%, primary amenorrhea in 2% and polymenorrhea in 8%. The current prevalence of primary amenorrhea differed between sports disciplines (p = 0.002), while oligomenorrhea (p = 0.828) and secondary amenorrhea (p = 0.848) did not. The lifetime prevalence of primary amenorrhea (10%) and oligomenorrhea (74%) differed significantly between sports disciplines (p < 0.001 and p = 0.001), while secondary amenorrhea (40%) did not (p = 0.298). The current and lifetime prevalence of primary amenorrhea was higher in aesthetic sports disciplines, while the lifetime prevalence of oligomenorrhea was higher in endurance disciplines. Factors associated with lower prevalences of MD were menstrual cycle tracking (p < 0.001), higher gynecological age (p < 0.001), regular gynecological health screenings (p = 0.008), and a diagnosed eating disorder (p = 0.037). Twenty-nine percent of these elite athletes used HC, of whom 15% claimed to use HC as a treatment for MD.</p><p><strong>Conclusion: </strong>Elite female athletes from a variety of sports disciplines, not just from endurance and aesthetic sports, are at high risk of developing MD. Given the high percentage of athletes using HC to treat MD, educating athletes, coaches, others from the support team and parents about the risk and prevention of MD and the effects of HC in the context of elite sports may improve gynecological health among elite athletes.</p>","PeriodicalId":21788,"journal":{"name":"Sports Medicine - Open","volume":"11 1","pages":"49"},"PeriodicalIF":5.9000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12058627/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prevalence of Menstrual Dysfunction and Hormonal Contraceptive Use Among Elite Female Athletes from Different Sports in Germany.\",\"authors\":\"Elisabeth M Kirschbaum, Katharina Fischer, Dorothee Speiser, Franziska Lautenbach, Friedemann Schwenkreis, Anne Dathan-Stumpf, Kirsten Legerlotz\",\"doi\":\"10.1186/s40798-025-00845-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>While a regular menstrual cycle is an indicator of good health, menstrual dysfunction (MD) and wrong beliefs regarding hormonal contraceptives (HC) are quite common among elite female athletes and threaten their health. This study aimed to (1) identify the prevalence of current and lifetime MD in various sports disciplines, (2) investigate variables that are associated with the prevalence of MD, (3) study the current practice of HC use among elite German female athletes.</p><p><strong>Methods: </strong>584 German elite female athletes (mean 20.7 ± 4.9 years) from 64 different sports completed an online questionnaire to assess gynecological health characteristics, history of MD, and the use of HC.</p><p><strong>Results: </strong>Sixty-nine percent of athletes not using HC reported a regular menstrual cycle, while oligomenorrhea was currently reported in 13%, secondary amenorrhea in 8%, primary amenorrhea in 2% and polymenorrhea in 8%. The current prevalence of primary amenorrhea differed between sports disciplines (p = 0.002), while oligomenorrhea (p = 0.828) and secondary amenorrhea (p = 0.848) did not. The lifetime prevalence of primary amenorrhea (10%) and oligomenorrhea (74%) differed significantly between sports disciplines (p < 0.001 and p = 0.001), while secondary amenorrhea (40%) did not (p = 0.298). The current and lifetime prevalence of primary amenorrhea was higher in aesthetic sports disciplines, while the lifetime prevalence of oligomenorrhea was higher in endurance disciplines. Factors associated with lower prevalences of MD were menstrual cycle tracking (p < 0.001), higher gynecological age (p < 0.001), regular gynecological health screenings (p = 0.008), and a diagnosed eating disorder (p = 0.037). Twenty-nine percent of these elite athletes used HC, of whom 15% claimed to use HC as a treatment for MD.</p><p><strong>Conclusion: </strong>Elite female athletes from a variety of sports disciplines, not just from endurance and aesthetic sports, are at high risk of developing MD. Given the high percentage of athletes using HC to treat MD, educating athletes, coaches, others from the support team and parents about the risk and prevention of MD and the effects of HC in the context of elite sports may improve gynecological health among elite athletes.</p>\",\"PeriodicalId\":21788,\"journal\":{\"name\":\"Sports Medicine - Open\",\"volume\":\"11 1\",\"pages\":\"49\"},\"PeriodicalIF\":5.9000,\"publicationDate\":\"2025-05-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12058627/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sports Medicine - Open\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s40798-025-00845-6\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SPORT SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sports Medicine - Open","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40798-025-00845-6","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SPORT SCIENCES","Score":null,"Total":0}
引用次数: 0

摘要

背景:虽然月经周期规律是身体健康的标志,但在优秀女运动员中,月经功能障碍(MD)和对激素避孕药(HC)的错误观念相当普遍,并威胁着她们的健康。本研究旨在(1)确定各种体育学科中当前和终生MD的患病率,(2)调查与MD患病率相关的变量,(3)研究德国优秀女运动员目前使用HC的情况。方法:来自64个不同运动项目的584名德国优秀女运动员(平均20.7±4.9岁)完成了一份在线问卷,以评估妇科健康特征、MD病史和HC的使用情况。结果:69%未使用HC的运动员报告月经周期正常,而目前报告的少经率为13%,继发性闭经率为8%,原发性闭经率为2%,多经率为8%。目前原发性闭经的患病率在不同运动学科之间存在差异(p = 0.002),而少经(p = 0.828)和继发性闭经(p = 0.848)没有差异。原发性闭经(10%)和少经(74%)的终生患病率在不同运动学科之间存在显著差异(p)。来自各种运动学科的优秀女运动员,不仅仅是耐力运动和审美运动,都有很高的患MD的风险。鉴于运动员使用HC治疗MD的比例很高,教育运动员、教练、其他支持团队和家长关于MD的风险和预防以及HC在精英运动背景下的影响可能会改善精英运动员的妇科健康。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Prevalence of Menstrual Dysfunction and Hormonal Contraceptive Use Among Elite Female Athletes from Different Sports in Germany.

Prevalence of Menstrual Dysfunction and Hormonal Contraceptive Use Among Elite Female Athletes from Different Sports in Germany.

Prevalence of Menstrual Dysfunction and Hormonal Contraceptive Use Among Elite Female Athletes from Different Sports in Germany.

Prevalence of Menstrual Dysfunction and Hormonal Contraceptive Use Among Elite Female Athletes from Different Sports in Germany.

Background: While a regular menstrual cycle is an indicator of good health, menstrual dysfunction (MD) and wrong beliefs regarding hormonal contraceptives (HC) are quite common among elite female athletes and threaten their health. This study aimed to (1) identify the prevalence of current and lifetime MD in various sports disciplines, (2) investigate variables that are associated with the prevalence of MD, (3) study the current practice of HC use among elite German female athletes.

Methods: 584 German elite female athletes (mean 20.7 ± 4.9 years) from 64 different sports completed an online questionnaire to assess gynecological health characteristics, history of MD, and the use of HC.

Results: Sixty-nine percent of athletes not using HC reported a regular menstrual cycle, while oligomenorrhea was currently reported in 13%, secondary amenorrhea in 8%, primary amenorrhea in 2% and polymenorrhea in 8%. The current prevalence of primary amenorrhea differed between sports disciplines (p = 0.002), while oligomenorrhea (p = 0.828) and secondary amenorrhea (p = 0.848) did not. The lifetime prevalence of primary amenorrhea (10%) and oligomenorrhea (74%) differed significantly between sports disciplines (p < 0.001 and p = 0.001), while secondary amenorrhea (40%) did not (p = 0.298). The current and lifetime prevalence of primary amenorrhea was higher in aesthetic sports disciplines, while the lifetime prevalence of oligomenorrhea was higher in endurance disciplines. Factors associated with lower prevalences of MD were menstrual cycle tracking (p < 0.001), higher gynecological age (p < 0.001), regular gynecological health screenings (p = 0.008), and a diagnosed eating disorder (p = 0.037). Twenty-nine percent of these elite athletes used HC, of whom 15% claimed to use HC as a treatment for MD.

Conclusion: Elite female athletes from a variety of sports disciplines, not just from endurance and aesthetic sports, are at high risk of developing MD. Given the high percentage of athletes using HC to treat MD, educating athletes, coaches, others from the support team and parents about the risk and prevention of MD and the effects of HC in the context of elite sports may improve gynecological health among elite athletes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Sports Medicine - Open
Sports Medicine - Open SPORT SCIENCES-
CiteScore
7.00
自引率
4.30%
发文量
142
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信